Published in J Aerosol Med on January 01, 2001
Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers. AAPS J (2012) 1.20
Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere™ technology. J Aerosol Med Pulm Drug Deliv (2011) 1.18
The Diskus: a review of its position among dry powder inhaler devices. Int J Clin Pract (2007) 1.09
Role of tiotropium in the treatment of COPD. Int J Chron Obstruct Pulmon Dis (2007) 0.99
Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch. Int J Chron Obstruct Pulmon Dis (2015) 0.87
Pretreatment with inhaled procaterol improves symptoms of dyspnea and quality of life in patients with severe COPD. Int J Gen Med (2012) 0.77
A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter? BMC Pulm Med (2016) 0.75
Patients' perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®). Patient Prefer Adherence (2016) 0.75
Devices for dry powder drug delivery to the lung. AAPS PharmSciTech (2015) 0.75
Concept review of dry powder inhalers: correct interpretation of published data. Multidiscip Respir Med (2015) 0.75
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J (2002) 4.68
Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax (2003) 4.53
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J (2002) 3.66
Regular vs as-needed inhaled salbutamol in asthma control. Lancet (1994) 3.59
Bronchodilator responsiveness in patients with COPD. Eur Respir J (2008) 3.13
Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest (1994) 2.15
Frequency and natural history of rhinovirus infections in adults during autumn. J Clin Microbiol (1997) 2.09
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur Respir J (2007) 2.03
Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Eur Respir J (2010) 2.01
Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials. Chest (1996) 1.82
Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med (2001) 1.69
The shape of the maximum expiratory flow volume curve. Chest (1988) 1.69
Physiologic and nonphysiologic determinants of aerobic fitness in mild to moderate asthma. Am Rev Respir Dis (1992) 1.66
Carcinogenicity of cadmium chloride aerosols in W rats. J Natl Cancer Inst (1983) 1.63
Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. Life Sci (1999) 1.58
Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial. Eur Respir J (2009) 1.52
Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.51
Bronchiolitis obliterans after lung transplantation: a review. Chest (1998) 1.45
The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group. Chest (2000) 1.43
Adverse effects of inhaled corticosteroids. Am J Med (1995) 1.39
Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax (2003) 1.31
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA (1999) 1.28
Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. Chest (1999) 1.20
Formaldehyde (CH2O) concentrations in the blood of humans and Fischer-344 rats exposed to CH2O under controlled conditions. Am Ind Hyg Assoc J (1985) 1.20
Psychological functioning and quality of life in lung transplant candidates and recipients. Chest (2000) 1.20
Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis (2009) 1.19
Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD. Pulm Pharmacol Ther (2005) 1.19
One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm Pharmacol Ther (2004) 1.17
Tolerance to bronchodilating effects of salmeterol in COPD. Respir Med (2003) 1.15
The six-minute walk test: a guide to assessment for lung transplantation. J Heart Lung Transplant (1997) 1.14
Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol (1995) 1.13
Comparison of hallway and treadmill six-minute walk tests. Am J Respir Crit Care Med (1999) 1.11
Extrathoracic angiomyolipomas in lymphangioleiomyomatosis. Eur Respir J (1996) 1.08
Aspergillus infection in single and double lung transplant recipients. Transplantation (1996) 1.06
Immunological and respiratory findings in spice-factory workers. Environ Res (1988) 1.05
COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT). Respir Med (2010) 1.05
Factors associated with emergency department dependence of patients with asthma. Chest (1997) 1.04
Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans. Transplantation (1997) 1.04
Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med (2007) 1.01
The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD. Chest (1999) 0.98
Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT®). Respir Med (2013) 0.96
Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J (2009) 0.94
A ten-year follow-up study of cotton textile workers. Am Rev Respir Dis (1991) 0.93
Assessment of patient performance of the HandiHaler compared with the metered dose inhaler four weeks after instruction. Respir Med (2003) 0.93
Variability in performance of timed walk tests in pulmonary rehabilitation programs. Chest (2000) 0.93
Organic dust disease of airways. Int Arch Occup Environ Health (1993) 0.92
Respiratory findings in spice factory workers. Arch Environ Health (1988) 0.92
Smoking and cotton dust effects in cotton textile workers: an analysis of the shape of the maximum expiratory flow volume curve. Environ Health Perspect (1986) 0.90
Respiratory symptoms and lung function in hemp workers. Br J Ind Med (1990) 0.90
Pleural complications in lung transplant recipients. J Thorac Cardiovasc Surg (1995) 0.90
Low level chromium (VI) inhalation effects on alveolar macrophages and immune functions in Wistar rats. Arch Toxicol (1985) 0.89
Airway effects of low concentrations of sulfur dioxide: dose-response characteristics. Arch Environ Health (1984) 0.88
Prior diagnosis and treatment of patients with normal results of methacholine challenge and unexplained respiratory symptoms. Chest (1996) 0.88
Exhaled nitric oxide in human lung transplantation. A noninvasive marker of acute rejection. Am J Respir Crit Care Med (1998) 0.88
Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients. Chest (1996) 0.88
A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma. Chest (1996) 0.87
Immunological findings and respiratory function in cotton textile workers. Int Arch Occup Environ Health (1992) 0.87
The placebo effect in asthma drug therapy trials: a meta-analysis. J Asthma (2000) 0.87
Causes of death in lung transplant recipients. J Heart Lung Transplant (1995) 0.87
Return to work after lung transplantation. J Heart Lung Transplant (1998) 0.86
Airway reactivity and cotton bract-induced bronchial obstruction. Chest (1985) 0.86
Respiratory symptoms and ventilatory capacity in soy bean workers. Am J Ind Med (1988) 0.86
Hepatitis C virus infection and lung transplantation: a survey of practices. J Heart Lung Transplant (1999) 0.86
Ipratropium bromide hydrofluoroalkane inhalation aerosol is safe and effective in patients with COPD. Chest (2001) 0.86
Quality of life in female lung transplant candidates and recipients. Chest (1997) 0.85
Analysis of inhaled corticosteroid and oral theophylline use among patients with stable COPD from 1987 to 1995. Chest (1999) 0.85
Assessment of an ambulatory care asthma program. J Asthma (1994) 0.85
Respiratory symptoms associated with sulfur dioxide exposure. Int Arch Occup Environ Health (1985) 0.84
Status of lung transplant recipients surviving beyond five years. J Heart Lung Transplant (1997) 0.84
A study of respiratory effects from exposure to 2 ppm formaldehyde in healthy subjects. Arch Environ Health (1986) 0.84
Miliary pulmonary cryptococcosis in a patient with the acquired immunodeficiency syndrome. Thorax (1993) 0.83
Effect of tiotropium bromide on the cardiovascular response to exercise in COPD. Respir Med (2007) 0.82
Mechanically assisted ventilation in a community hospital. Immediate outcome, hospital charges, and follow-up of patients. Arch Intern Med (1985) 0.82
Severe pulmonary hypertension associated with COPD. Ann Transplant (2000) 0.82
Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax (2006) 0.82
Effects of NiO inhalation on alveolar macrophages and the humoral immune systems of rats. Ecotoxicol Environ Saf (1984) 0.81
Airway responses to sulfur dioxide and methacholine in asthmatics. J Occup Med (1985) 0.81
Asthma and allergy avoidance knowledge and behavior in postpartum women. Ann Allergy Asthma Immunol (1997) 0.81
Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation. Chest (1993) 0.81
Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant (1996) 0.81
Prehospitalization inhaled corticosteroid use in patients with COPD or asthma. Chest (1997) 0.81
Carcinogenicity of sodium dichromate and chromium (VI/III) oxide aerosols inhaled by male Wistar rats. Toxicology (1986) 0.81
Acute effects of herbal tea dust extracts on lung function. Chest (1989) 0.80
Lung volume reduction surgery: an analysis of hospital costs. Chest (1998) 0.80
Effects of high-dose inhaled fluticasone propionate via spacer on cell-mediated immunity in healthy volunteers. Chest (2000) 0.80
The acute effects of nasal positive pressure ventilation in patients with advanced cystic fibrosis. Chest (1998) 0.80
Analysis of the T cell receptor Vgamma region gene repertoire in bronchoalveolar lavage (BAL) and peripheral blood of atopic asthmatics and healthy subjects. Clin Exp Immunol (1996) 0.80
Respiratory function in animal food processing workers. Am J Ind Med (1989) 0.80
Immunological and respiratory changes in soy bean workers. Int Arch Occup Environ Health (1991) 0.80
Immunological and respiratory changes in animal food processing workers. Am J Ind Med (1992) 0.79
A retrospective comparative study of in-hospital management of acute severe asthma: 1984 vs 1989. Chest (1993) 0.79
A study of respiratory effects from exposure to 2.0 ppm formaldehyde in occupationally exposed workers. Environ Res (1987) 0.79
Immunological findings in hemp workers. Environ Res (1992) 0.78
Detection of sulfur dioxide in bronchodilator aerosols. Chest (1984) 0.78
Fenoterol in exercise-induced asthma. Effect of dose on efficacy and duration of action. Chest (1984) 0.78